A Study to Investigate the Effects of Brensocatib on QT Interval in Healthy Participants
Status:
Recruiting
Trial end date:
2022-09-29
Target enrollment:
Participant gender:
Summary
The study has 2 Parts: The primary purpose of Part 1 is to determine the supratherapeutic
dose of brensocatib to be used in Part 2 of the study.
The primary purpose of Part 2 is to assess brensocatib's potential for prolonging the QT
interval.